117 results
Search Results
2. Prenatal exposure to escitalopram and/or stress in rats: A prenatal stress model of maternal depression and its treatment
3. Dopamine D2/3 occupancy of ziprasidone across a day: a within-subject PET study
4. Evaluation of chemically diverse 5-HT2C receptor agonists on behaviours motivated by food and nicotine and on side effect profiles
5. Morphine-induced motor stimulation, motor incoordination, and hypothermia in adolescent and adult mice
6. Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
7. Smoking produces rapid rise of [11C]nicotine in human brain
8. Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women
9. Evaluation of a pharmacokinetic hypothesis for reduced locomotor stimulation from methamphetamine and cocaine in adolescent versus adult male C57BL/6J mice
10. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC
11. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance
12. Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose
13. Effects of pregnancy on nicotine self-administration and nicotine pharmacokinetics in rats
14. A critical transition in cocaine self-administration: behavioral and neurobiological implications
15. Simultaneous intra-accumbens remifentanil and dopamine kinetics suggest that neither determines within-session operant responding
16. Safety of intravenous methamphetamine administration during treatment with bupropion
17. Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes
18. Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization
19. [N-methyl-11C]Mirtazapine for positron emission tomography neuroimaging of antidepressant actions in humans
20. Effect of social isolation on the metabolism of morphine and its passage through the blood-brain barrier and on consumption of sucrose solutions
21. Cocaine pharmacodynamics after intravenous and oral administration in rats: relation to pharmacokinetics
22. Immunization of rats reduces nicotine distribution to brain
23. Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects
24. Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017
25. Lack of multiple dosing effect of sertindole on the pharmacokinetics of alprazolam in healthy volunteers
26. Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel®) in patients with schizophrenia
27. Naltrexone effects on diazepam intoxication and pharmacokinetics in humans
28. Independent interaction of alprazolam and caffeine under chronic dose regimens on differential reinforcement of low-rate (DRL 45-s) performance
29. Combined effects of ethanol and cocaine on FOS-like protein and cocaethylene biosynthesis in the rat
30. Individual differences in dopamine release but not rotational behavior correlate with extracellular amphetamine levels in caudate putamen in unlesioned rats
31. Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics
32. Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics
33. Individual differencs in dopamine release but not rotational behavior correlate with extracellular amphetamine levels in caudate putament in unlesioned rats
34. The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography
35. Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects
36. Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man
37. Pharmacokinetic and pharmacodynamic responses to caffeine in poor and normal sleepers
38. Relationship between the discriminative stimulus effects and plasma concentrations of intramuscular cocaine in rhesus monkeys
39. Alcohol pharmacodynamics in young-elderly adults contrasted with young and middle-aged subjects
40. Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine
41. Pharmacokinetics and bioavailability of benperidol in schizophrenic patients after intravenous and two different kinds of oral application
42. Differences in bioavailability between cocaine and cocaethylene and their implications for drug-reward studies
43. Effects of oxazepam on eye movements and performance in vigilance tasks with static and dynamic stimuli
44. Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat
45. Subjective and behavioral effects of diazepam depend on its rate of onset
46. An open study of the pharmacokinetics and the tolerability of raclopride extended release capsules in psychiatric patients
47. Functional consequences of acute cocaine treatment depend on route of administration
48. Nicotine elimination and tolerance in non-dependent cigarette smokers
49. Imipramine and 2-hydroxyimipramine: comparative cardiotoxicity and pharmacokinetics in swine
50. Determination of haloperidol and reduced haloperidol in the plasma and blood of patients on depot haloperidol
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.